Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity

Overview of attention for article published in Molecular Cancer, February 2018

Altmetric Badge

Citations

So far, Dimensions has found 13 publications that cite this research output.

Article in Chemistry & Biodiversity (September 2023)

Article in Bioorganic Chemistry (July 2023)

Article in Molecular Cancer (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.